Most people find allergy information on food labels unclear

When researchers evaluated consumers’ understanding of allergy information on food labels, less than half of individuals found the information to be clear. The study, which is published in Clinical & Experimental Allergy, involved two separate experiments with a total of 96 consumers with food allergies and 105 without. Investigators first randomly presented 18 different food products with labels suggesting peanut […]

Read more

Antibody tests, even rapid finger pricks, are effective COVID-19 screening tools

New findings from a Michigan Medicine study reveal that antibody testing is predictive of prior COVID-19 infection, and rapid screening methods – even from finger pricks – are effective testing tools. Researchers analyzed antibody tests conducted on more than 500 subjects in patient care settings. They found that people who had COVID, including those with mild symptoms, produced antibodies. "For […]

Read more

NIAID experts outline the emergence of significant variants of SARS-CoV-2

What: The rise of several significant variants of SARS-CoV-2, the virus that causes COVID-19, has attracted the attention of health and science experts worldwide. In an editorial published in JAMA: The Journal of the American Medical Association, experts from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, outline how these variants have […]

Read more

Zovirax Ophthalmic Ointment

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ZOVIRAX OPHTHALMIC (EYE) OINTMENT Acyclovir Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Zovirax ophthalmic ointment. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have […]

Read more

Lucrin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LUCRIN® INJECTION Leuprorelin acetate Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Lucrin Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks […]

Read more

Nivestim

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NIVESTIM® Filgrastim [rbe] (fil-GRAS-tim) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Nivestim. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. […]

Read more

Aloxi

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ALOXI® Palonosetron 250 microgram per 5 mL solution for injection; Palonosetron 75 microgram per 1.5 mL solution for injection Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ALOXI. It does not contain all the available information. It does not take […]

Read more

Xgeva

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. XGEVA® Denosumab(rch) – den”-os”-u”-mab Consumer Medicine Information (CMI) What is in this CMI What is in this CMI What Xgeva is used for Before you are given it When you must not be given it Before you are given it Taking other medicines How it is given […]

Read more

Tevatrexed

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TEVATREXED® VERSION 1.0 Pemetrexed disodium Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Pemetrexed. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet […]

Read more
1 2 3 6